Chronic arthritis related to SARS-CoV-2 infection in a pediatric patient: A case report

Crivelenti, Luísa Rosa de Morais Palma; Frazão, Marina Martins Nascimento; Maia, Marina Paiva de Melo; Gomes, Francisco Hugo Rodrigues; Carvalho, Luciana

doi:10.1016/j.bjid.2021.101585

Cited by 11 publications

(12 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Associated cutaneous findings were reported in six cases and included maculopapular rash, urticaria, lesions consistent with psoriasis, palpable purpura, pruritic clearly demarcated erythematous scaly patches, and leukoderma with an associated unspecified rash. 12 , 15 , 18 , 24 , 32 , 39 The diagnostic work-up varied across cases with most authors reporting results of one or more inflammatory markers and auto-antibody panels. However, arthrocentesis with synovial fluid analysis was only reported for 19 cases.…”

Section: Resultsmentioning

confidence: 99%

The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature

et al. 2022

View full text Add to dashboard Cite

Background Given the widespread impact of COVID-19, it is important to explore any atypical presentations and long-term sequelae associated with this viral infection, including the precipitation of inflammatory arthritis. Objective To identify and summarize clinical reports of acute inflammatory arthritis associated with COVID-19. Methods A systematic review of the PubMed (MEDLINE), Google Scholar, and Cochrane Central databases through January 31, 2022 was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. The inclusion criteria were: human subjects and English language. Data extraction and qualitative synthesis of the demographics, clinical presentations, treatments, and outcomes were performed. Quality assessment was performed using the Joanna-Briggs Institute critical appraisal tools. Results A total of 37 articles collectively describing the cases of 54 patients were included. The mean age was 48.2 years (6-78 years). 53.7% of patients were male and 46.3% were female. The onset of articular symptoms varied considerably, and the majority of cases were described as polyarticular (29). The classification of inflammatory arthritis in the included studies was as follows: reactive (19), post-viral (13), new-onset rheumatoid arthritis (RA) (8), crystal-proven arthropathy flare (4), acute viral (2), new-onset psoriatic arthritis (2), flare of preexisting RA (2), and other (4). Arthritis treatment regimens varied but consisted largely of NSAIDs and corticosteroids with most patients experiencing improvement or resolution of their joint symptoms. Conclusion There is limited low-level evidence suggesting that patients may develop acute arthritis during or after SARS-CoV-2 infection. This review highlights the need for further research to elucidate the relationship between COVID-19 and the development of inflammatory arthritis.

show abstract

Section: Resultsmentioning

confidence: 99%

The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature

et al. 2022

View full text Add to dashboard Cite

show abstract

“… 2 , 3 There are multiple case reports of spondyloarthritis-related reactive arthritis following COVID-19 infection with resolution following cessation of inflammatory response. 4 – 11 …”

Section: Discussionmentioning

confidence: 99%

“…There are multiple case reports of spondyloarthritis-related reactive arthritis following COVID-19 infection with resolution following cessation of inflammatory response. [4][5][6][7][8][9][10][11] Various viral infections have been postulated to induce autoimmunity in genetically predisposed individuals to include parvovirus B19, cytomegalovirus (CMV), hepatitis A/C, herpes virus 6, rubella virus, and chikungunya virus (CHIKV). 2 Arthritogenic alphavirus belonging to the genus Alphavirus of the Togiviridae such as CHIKV have had rheumatic manifestations following resolution of the acute disease.…”

Section: Discussionmentioning

confidence: 99%

COVID-19-induced psoriatic arthritis: a case report

Essien

Chastant

McNulty

et al. 2022

Therapeutic Advances in Chronic Disease

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which may lead to uncontrolled immune activation and cytokine response in some. The pattern of pro-inflammatory cytokines is similar to that which has been observed to be involved in rheumatic diseases and target treatments. Viral arthritis is common with a wide variety in spectrum ranging from arthralgia to spurious and chronic arthritis. However, recent studies have demonstrated a correlation with endemic coronaviruses and increased risk of developing rheumatoid arthritis (RA). Cases are being identified that describe a post-COVID reactive; however, to date, no report has been published describing the onset of psoriasis and concomitant development of psoriatic arthritis after COVID-19 infection. We report an interesting case of psoriatic arthritis in a post-COVID-19 infection patient with review of the current literature.

show abstract

“…Acute and PACS are characterized by a large panel of clinical manifestations ranging from asymptomatic symptoms to fatal respiratory failure, and are often associated with manifestations shared with SAD such as musculoskeletal, dermatological, pulmonary, digestive, cardiovascular, kidney injury, thromboembolic events and neurological symptoms [ 83 , 86 , 92 , [114] , [115] , [116] , [117] , [118] , [119] , [120] , [121] , [122] , [123] , [124] , [125] ]). Potential mechanisms contributing to SAD-associated clinical symptoms include direct virus replication in acute/chronic infection, inflammation, and immune changes in response to the infection [ 126 ].…”

Section: Sars-cov-2/covid19 Vaccination and Autoimmune And Chronic In...mentioning

confidence: 99%

SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases

Larionova

Byvaltsev

Кравцова

et al. 2022

Journal of Translational Autoimmunity

View full text Add to dashboard Cite

Chronic arthritis related to SARS-CoV-2 infection in a pediatric patient: A case report

Cited by 11 publications

References 19 publications

The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature

The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature

COVID-19-induced psoriatic arthritis: a case report

SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases

Contact Info

Product

Resources

About